While this study attributes a tumor suppressor role to TACSTD2 in PCa, we do acknowledge that this finding contradicts the findings of Hsu EC et al., who conversely stated that TACSTD2 is overexpressed in CRPC, drives cancer growth, and induces the neuroendocrine phenotype [23]. The gene discussed is TACSTD2; the disease is cancer.